# Clinicopathological Features and Treatment Strategies for Gastric Epithelial Neoplasm of Fundic-gland Mucosa Lineage

> **NCT07230054** · — · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 400 (actual)

## Conditions studied

- Gastric Epithelial Neoplasm of Fundic-gland Mucosa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07230054
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230054, "Clinicopathological Features and Treatment Strategies for Gastric Epithelial Neoplasm of Fundic-gland Mucosa Lineage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07230054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*